Summary MYOS RENS Technology Inc (MYOS RENS), formerly MYOS Corp is a bionutrition and biotherapeutics company that discovers, develops and commercializes products that improve muscle health and function.The company offers fortetropin, a unique bioactive composition derived from fertilized chicken egg yolk that is processed using a patented technology which preserves its biological integrity and bioactivity for increase of muscle size and lean body mass in conjunction with resistance training.
MYOS RENS’s biotherapeutics research and development activities are concentrated on medical health, nutrition, consumer health and animal health.It also undertakes human clinical trials and pre-clinical studies for the treatment of various diseases such as sarcopenia, cachexia and degenerative muscle disease.
The company partners with other institutions for its research and development activities. MYOS RENS is headquartered in Cedar Knolls, New Jersey, the US.
MYOS RENS Technology Inc (MYOS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
The inspection machines market is projected to reach USD 871 million by 2025 from USD 671 million in 2020, at a CAGR of 5.4%. Growth in this market is primarily driven by the increasing adoption of inspection systems throughout their production lines due to the growing concerns to the regulatory mandates introduced by the government and regulatory...
The Asia Pacific dermatology treatment devices market is expected to reach US$ 1,680.81 million in 2027 from US$ 962.14 million in 2019; it is estimated to grow with a CAGR of 7.4% from 2020 to 2027. The growth of this market is attributed to the key driving factors such as rising awareness regarding skin diseases and increasing demand...
Global Hospital Care Partnering 2014 to 2020 provides the full collection of Hospital Care disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Hospital Care partnering deals Financial deal terms for headline, upfront and royalty by stage of development Hospital...
Hip Reconstruction Devices - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Hip Reconstruction Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Hip Reconstruction Devices pipeline products with comparative analysis...
Vision Care Devices - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Vision Care Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Vision Care Devices pipeline products with comparative analysis of the products at...
Diabetes Assays - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Diabetes Assays - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Diabetes Assays pipeline products with comparative analysis of the products at various stages...
Trauma Fixation Devices - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Trauma Fixation Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Trauma Fixation Devices pipeline products with comparative analysis of the...
211 pages •
By Asia Market Information & Development Company
• Jan 2021
China’s demand for Anti Peptic Ulcer Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer...
290 pages •
By The Business Research Company
• Dec 2020
Antiglaucoma Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global antiglaucoma drugs market. Description: Where is the largest and fastest growing market for the antiglaucoma...